Spring Bio Solution will offer OneScan to pharmaceutical manufacturers across India, Europe, Singapore, and other key global ...

Nucleus RadioPharma, a contract development and manufacturing organization (CDMO) specializing in radiopharmaceuticals, has ...

Wegovy is now positioned as the first and only GLP-1 treatment.

The initiative aims to identify and support new ideas for innovative oral formulations for peptide drugs such as GLP-1 ...

FDA states substantial evidence of efficacy was not demonstrated.

IQVIA and Veeva Systems announced global clinical and commercial partnerships and the complete resolution of all pending ...

Systlmmune and BMS’ ACD treats patients with previously treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer.

Developed by Daiichi Sankyo and Merck, it treats patients with Pretreated Extensive-Stage Small Cell Lung Cancer.

In partnership with the University of Oxford’s Pandemic Sciences Institute, the grant will advance oral vaccine delivery.

Precigen, Inc., a biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the ...

AbbVie will invest $195 million in its North Chicago, Illinois, manufacturing plant to expand domestic API production in the ...

Bayer and Kumquat Biosciences have entered an exclusive global license and collaboration to develop and commercialize Kumquat ...